法制与社会发展
法製與社會髮展
법제여사회발전
Law and Social Development
2010年
2期
16~24
,共null页
人体基因 人格 财产 人格性财产权
人體基因 人格 財產 人格性財產權
인체기인 인격 재산 인격성재산권
human gene ; personality ; property ; personal property rights
按照经典权利理论中人/物、人格权/财产权的二元界分逻辑,人体基因作为整全的人身的组成部分,处于“人格权”的保护之下,被禁止用于谋利性交易。然而,随着基因科技的发展及基因的产业化应用,人/物的界限被内移到了人自身,人体基因也日益外化而具有独立的经济价值。当基因科技的施为力量已在某种程度上消弭了经典权利理论所依仗的人/物二元界分的基础时,试图非此即彼地以人格权或财产权来界定人体基因的法律属性,都不会实现关于基因利益的公平分配和确保人格不被减等的结果。问题的出路,似乎在于在人格权和财产权的混同处,提出一个新的“人格性财产权”的范畴界定人体基因的法律属性,并综合运用人格权和财产权的保护机制来保障基因资源提供者的利益。
按照經典權利理論中人/物、人格權/財產權的二元界分邏輯,人體基因作為整全的人身的組成部分,處于“人格權”的保護之下,被禁止用于謀利性交易。然而,隨著基因科技的髮展及基因的產業化應用,人/物的界限被內移到瞭人自身,人體基因也日益外化而具有獨立的經濟價值。噹基因科技的施為力量已在某種程度上消弭瞭經典權利理論所依仗的人/物二元界分的基礎時,試圖非此即彼地以人格權或財產權來界定人體基因的法律屬性,都不會實現關于基因利益的公平分配和確保人格不被減等的結果。問題的齣路,似乎在于在人格權和財產權的混同處,提齣一箇新的“人格性財產權”的範疇界定人體基因的法律屬性,併綜閤運用人格權和財產權的保護機製來保障基因資源提供者的利益。
안조경전권리이론중인/물、인격권/재산권적이원계분라집,인체기인작위정전적인신적조성부분,처우“인격권”적보호지하,피금지용우모리성교역。연이,수착기인과기적발전급기인적산업화응용,인/물적계한피내이도료인자신,인체기인야일익외화이구유독립적경제개치。당기인과기적시위역량이재모충정도상소미료경전권리이론소의장적인/물이원계분적기출시,시도비차즉피지이인격권혹재산권래계정인체기인적법률속성,도불회실현관우기인이익적공평분배화학보인격불피감등적결과。문제적출로,사호재우재인격권화재산권적혼동처,제출일개신적“인격성재산권”적범주계정인체기인적법률속성,병종합운용인격권화재산권적보호궤제래보장기인자원제공자적이익。
According to the dualist division of persona/rem, personal rights/property rights in classical theories of rights, human gene is categorized as personal rights and prohibited to profiting transaction since it is a part of an integrated human body. However, with the development of generic science and technology and the industrialization of genes, the boundary of persona/rein shifted to human itself, and human gene exteriorized to gain independent economic values. Since the power of genetic science and technology has in some extent undermined the basis of dualist division of persona/rem, it seems to unreasonable to apply this either/or approach to decide the legal nature of human gene for a fair distribution of interest and protecting personality form degrading. The way out lies in the combination of personal rights and property rights, and to set forth a new category of "personal property rights" in defining the legal nature of human gene, and the protection of interest of gene providers with an integrated mechanism.